Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 242 entries
View as:

Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00291668 Org: User:
Start: 03/02/06 End: 11/08/07 Due: 11/08/08

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01405508 Org: User:
Start: 08/31/11 End: 07/31/12 Due: 07/31/13

Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

Phase: N/A Priority: Normal
NCT ID: NCT00736931 Org: User:
Start: 07/31/08 End: 10/31/08 Due: 10/31/09

A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00594464 Org: User:
Start: 09/30/07 End: 05/31/08 Due: 05/31/09

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00955357 Org: User:
Start: 08/31/09 End: 08/31/13 Due: 08/31/14

Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00530855 Org: User:
Start: 02/29/08 End: 12/31/14 Due: 12/31/15

A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00150709 Org: User:
Start: 01/26/98 End: 01/25/06 Due: 01/25/07

Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT00383214 Org: User:
Start: 05/31/05 End: 03/31/07 Due: 03/31/08

Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

Phase: N/A Priority: Normal
NCT ID: NCT00484536 Org: User:
Start: 05/31/07 End: 07/31/10 Due: 07/31/11

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Phase: N/A Priority: Normal
NCT ID: NCT00136019 Org: User:
Start: 03/31/04 End: 08/31/06 Due: 08/31/07

Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema

Phase: N/A Priority: Normal
NCT ID: NCT00375713 Org: User:
Start: 10/31/05 End: 05/31/06 Due: 05/31/07

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Phase: N/A Priority: Normal
NCT ID: NCT00175825 Org: User:
Start: 11/07/05 End: 06/29/06 Due: 06/29/07

Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT00753454 Org: User:
Start: 09/30/08 End: 05/31/11 Due: 05/31/12

A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00235469 Org: User:
Start: 04/30/04 End: 06/30/05 Due: 06/30/06

Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00136045 Org: User:
Start: 05/31/05 End: 08/31/06 Due: 08/31/07

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00419393 Org: User:
Start: 12/31/07 End: 03/31/10 Due: 03/31/11

Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00349752 Org: User:
Start: 11/30/06 End: 07/31/09 Due: 07/31/10

Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00245765 Org: User:
Start: 10/31/05 End: 11/30/06 Due: 11/30/07

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Phase: N/A Priority: Normal
NCT ID: NCT01398956 Org: User:
Start: 06/30/11 End: 04/30/16 Due: 04/30/17

Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)

Phase: N/A Priority: Normal
NCT ID: NCT00329420 Org: User:
Start: 05/31/06 End: 05/31/08 Due: 05/31/09

Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01262794 Org: User:
Start: 11/30/10 End: 09/30/11 Due: 09/30/12

Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00498108 Org: User:
Start: 01/31/06 End: 09/30/07 Due: 09/30/08

Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias

Phase: N/A Priority: Normal
NCT ID: NCT00160576 Org: User:
Start: 07/31/03 End: 11/30/04 Due: 11/30/05

Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)

Phase: N/A Priority: Normal
NCT ID: NCT00567060 Org: User:
Start: 05/31/00 End: 01/31/04 Due: 01/31/05

Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT00152399 Org: User:
Start: 09/30/00 End: 10/31/05 Due: 10/31/06